Vistagen Therapeutics VTGN
NASDAQ VTGN
$0.19 -0.01 (-5.00%)
At close: Nov 19, 2026 · 4:00 PM EST

Vistagen Therapeutics (VTGN) Income from Continuing Operations (2009 - 2026)

Updated

Vistagen Therapeutics' Income from Continuing Operations was -$10.74 million in fiscal Q2 2027 (quarter ended Sep 30, 2026), compared with -$19.42 million a year earlier.

Analysis

Vistagen Therapeutics (VTGN) Income from Continuing Operations (2009 - 2026) Analysis & Trends

On a trailing twelve-month basis, Vistagen Therapeutics' Income from Continuing Operations was -$58.97 million through Sep 30, 2026; for FY2026 (ended Mar 31, 2026), it came in at -$69.71 million.

  • In earlier fiscal years, Income from Continuing Operations was -$51.42 million in FY2025, -$29.36 million in FY2024, -$59.25 million in FY2023 and -$47.76 million in FY2022.
  • The fiscal Q2 2027 figure marks the highest quarterly Income from Continuing Operations since fiscal Q1 2025.
  • Per Business Quant data, VTGN's Income from Continuing Operations in the three fiscal quarters before Q2 2027 was -$13.03 million (Q1 2027), -$16.3 million (Q4 2026) and -$18.9 million (Q3 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00 -1.95 Mn
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn 6.45 Bn
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn 210.00 Mn
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn 4.22 Bn
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn 5.07 Bn
6 Novartis Ag 291.91 Bn 265.14 Bn - -
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn 3.86 Bn
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn 2.43 Bn
9 Gsk 193.54 Bn 176.38 Bn - -
10 Vistagen Therapeutics 7.34 Mn -151.60 Mn - -10.74 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -10.74 Mn
Jun 30, 2026 -13.03 Mn
Mar 31, 2026 -16.30 Mn
Dec 31, 2025 -18.90 Mn
Sep 30, 2025 -19.42 Mn
Jun 30, 2025 -15.10 Mn
Mar 31, 2025 -13.64 Mn
Dec 31, 2024 -14.09 Mn
Sep 30, 2024 -12.96 Mn
Jun 30, 2024 -10.73 Mn
Mar 31, 2024 -9.52 Mn
Dec 31, 2023 -6.35 Mn
Sep 30, 2023 -6.59 Mn
Jun 30, 2023 -6.90 Mn
Mar 31, 2023 -12.23 Mn
Dec 31, 2022 -9.76 Mn
Sep 30, 2022 -17.48 Mn
Jun 30, 2022 -19.78 Mn
Mar 31, 2022 -16.69 Mn
Dec 31, 2021 -10.53 Mn
API Access

Vistagen Therapeutics Income from Continuing Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=VTGN&period=max&api_key=YOUR_API_KEY